26 - 30 of 252 documents
6 Nov 2017
NCRI Cancer Conference
The model was shown to robustly classify both progressive and non-progressive samples with an AUC of 79% using default cutoffs. At the pathological...
3 Nov 2017
Pre-clinical mouse models suggest that the gut microbiome modulates tumor response to checkpoint blockade immunotherapy; however, this has not been...
2 Nov 2017
Public Health England
Executive summary of quality assurance (QA) visit in North Central London held on 15 November 2016.   Click here to read the '...
1 Nov 2017
AACR Publications
The PARP inhibitor (PARPi) talazoparib may potentiate activity of chemotherapy and toxicity in cells vulnerable to DNA damage. This phase I...
1 Nov 2017
Public Health Agency NI
This leaflet highlights the potential signs and symptoms of breast cancer.   Click to read the leaflet in full